Pathways to biomedical tipping points: Vertical, horizontal or other

Mark J. Ahn, Anne S. York, Polly Rizova

Research output: Contribution to journalReview article

9 Scopus citations


Breakthrough innovations in biomedical technologies such as treatments, devices and diagnostics are increasingly addressing complex medical needs and yielding significant scientific progress. The pathways to their commercial success, however, are poorly understood. In contrast to recent calls for a return to vertical integration, we suggest that relying on strong and unique horizontal relationships among biomedical organizations is more likely to shape technology convergence and increase success rates in achieving a tipping point or critical mass to address unmet medical needs, build new intellectual property and extend profitable growth from served markets.

Original languageEnglish
Pages (from-to)224-238
Number of pages15
JournalJournal of Commercial Biotechnology
Issue number3
Publication statusPublished - Jul 2010


All Science Journal Classification (ASJC) codes

  • Biotechnology
  • Management of Technology and Innovation
  • Economics and Econometrics

Cite this